2017 Q2 Form 10-Q Financial Statement

#000156459017017119 Filed on August 10, 2017

View on sec.gov

Income Statement

Concept 2017 Q2 2016 Q4 2016 Q2
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.270M $1.060M $980.0K
YoY Change 29.59% -51.82% -43.35%
% of Gross Profit
Research & Development $4.078M $930.0K $1.428M
YoY Change 185.54% -86.77% -80.88%
% of Gross Profit
Depreciation & Amortization $10.00K $20.00K $20.00K
YoY Change -50.0% 0.0% 0.0%
% of Gross Profit
Operating Expenses $6.358M $1.980M $2.520M
YoY Change 152.32% -78.55% -72.61%
Operating Profit -$6.358M -$2.520M
YoY Change 152.32% -72.61%
Interest Expense $10.00K $10.00K -$250.0K
YoY Change -104.0% -103.57% -10.71%
% of Operating Profit
Other Income/Expense, Net $154.0K
YoY Change
Pretax Income -$6.512M -$1.970M -$2.660M
YoY Change 144.81% -79.31% -71.94%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$6.512M -$1.970M -$2.657M
YoY Change 145.04% -79.31% -71.97%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$1.216M -$852.8K -$1.142M
COMMON SHARES
Basic Shares Outstanding 13.83M
Diluted Shares Outstanding

Balance Sheet

Concept 2017 Q2 2016 Q4 2016 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $7.600M $11.50M $21.50M
YoY Change -64.65% -69.5% -65.87%
Cash & Equivalents $1.027M $11.68M $21.47M
Short-Term Investments
Other Short-Term Assets $500.0K $1.000M $800.0K
YoY Change -37.5% -50.0% 0.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $8.100M $12.50M $22.20M
YoY Change -63.51% -68.53% -65.2%
LONG-TERM ASSETS
Property, Plant & Equipment $0.00 $109.3K $200.0K
YoY Change -100.0% -41.34% 0.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $100.0K $200.0K $200.0K
YoY Change -50.0% 0.0% 0.0%
Total Long-Term Assets $100.0K $316.7K $400.0K
YoY Change -75.0% -18.03% 0.0%
TOTAL ASSETS
Total Short-Term Assets $8.100M $12.50M $22.20M
Total Long-Term Assets $100.0K $316.7K $400.0K
Total Assets $8.200M $12.82M $22.60M
YoY Change -63.72% -68.05% -64.8%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $500.0K $503.7K $1.100M
YoY Change -54.55% -87.46% -63.33%
Accrued Expenses $1.200M $398.5K $1.500M
YoY Change -20.0% -82.68% -16.67%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $1.190M
YoY Change -100.0% -0.8%
Total Short-Term Liabilities $1.700M $902.2K $3.732M
YoY Change -54.45% -90.09% -37.8%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $2.810M
YoY Change -100.0% -100.0% -67.33%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $2.810M
YoY Change -100.0% -100.0% -67.33%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.700M $902.2K $3.732M
Total Long-Term Liabilities $0.00 $0.00 $2.810M
Total Liabilities $1.700M $900.0K $6.542M
YoY Change -74.01% -94.48% -55.19%
SHAREHOLDERS EQUITY
Retained Earnings -$131.7M -$125.9M -$121.5M
YoY Change 8.36% 11.54%
Common Stock $138.2M $137.8M $137.6M
YoY Change 0.46% 0.82%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $6.513M -$181.1M $16.04M
YoY Change
Total Liabilities & Shareholders Equity $8.214M $12.82M $22.58M
YoY Change -63.63% -68.05% -64.83%

Cashflow Statement

Concept 2017 Q2 2016 Q4 2016 Q2
OPERATING ACTIVITIES
Net Income -$6.512M -$1.970M -$2.657M
YoY Change 145.04% -79.31% -71.97%
Depreciation, Depletion And Amortization $10.00K $20.00K $20.00K
YoY Change -50.0% 0.0% 0.0%
Cash From Operating Activities -$2.160M -$2.880M -$2.630M
YoY Change -17.87% -78.78% -66.33%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 0.000 20.00K
YoY Change -100.0% -100.0% -50.0%
NET CHANGE
Cash From Operating Activities -2.160M -2.880M -2.630M
Cash From Investing Activities 0.000 0.000 0.000
Cash From Financing Activities 0.000 0.000 20.00K
Net Change In Cash -2.160M -2.880M -2.610M
YoY Change -17.24% -78.68% -66.41%
FREE CASH FLOW
Cash From Operating Activities -$2.160M -$2.880M -$2.630M
Capital Expenditures $0.00 $0.00
Free Cash Flow -$2.880M -$2.630M
YoY Change -78.78% -66.33%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.42
CY2016Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
137763499
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-125850355
CY2017Q2 us-gaap Stockholders Equity
StockholdersEquity
6512654
CY2017Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2016Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2017Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2016Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2017Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2017Q2 us-gaap Operating Expenses
OperatingExpenses
2827914
CY2016Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
154057
us-gaap Interest Expense Debt
InterestExpenseDebt
419181
CY2016Q2 us-gaap Net Income Loss
NetIncomeLoss
-2657489
us-gaap Net Income Loss
NetIncomeLoss
-8684045
CY2017Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.20
CY2016Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.19
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.63
CY2017Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
13831747
CY2016Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
13800997
us-gaap Depreciation And Amortization
DepreciationAndAmortization
18658
us-gaap Depreciation And Amortization
DepreciationAndAmortization
35424
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-55705
us-gaap Paid In Kind Interest
PaidInKindInterest
100322
us-gaap Share Based Compensation
ShareBasedCompensation
422069
us-gaap Share Based Compensation
ShareBasedCompensation
887363
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-527408
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1219320
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
798702
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-3801309
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-4004858
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-10242925
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
5500
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
5500
CY2017Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1151918
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
1382
CY2017Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
93382
CY2016Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
200000
CY2016Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
398453
CY2017Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2016Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2017Q2 us-gaap Common Stock Value
CommonStockValue
1383
CY2017Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
138189026
CY2017Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-2827914
CY2016Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-2519838
CY2016Q4 us-gaap Assets
Assets
12816718
CY2017Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-131677755
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
109320
CY2016Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
503739
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
11914526
CY2017Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8213548
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
12816718
CY2017Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2016Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2017Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2016Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2017Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2017Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
13831747
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
13828496
CY2017Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13831747
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13828496
CY2017Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1556020
CY2016Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1428196
us-gaap Net Income Loss
NetIncomeLoss
-5827400
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
13779290
us-gaap Investment Income Interest
InvestmentIncomeInterest
26684
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
13819751
CY2017Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
14149
CY2017Q2 us-gaap Net Income Loss
NetIncomeLoss
-2813765
CY2016Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
16406
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2748153
CY2016Q2 us-gaap Operating Expenses
OperatingExpenses
2519838
us-gaap Operating Expenses
OperatingExpenses
5854084
us-gaap Operating Income Loss
OperatingIncomeLoss
-5854084
us-gaap Early Repayment Of Senior Debt
EarlyRepaymentOfSeniorDebt
5514058
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
485942
us-gaap Payments Of Loan Costs
PaymentsOfLoanCosts
52400
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
3459
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
18525
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
3459
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-6033875
neot Net Increase Decrease In Cash Cash Equivalents And Restricted Cash
NetIncreaseDecreaseInCashCashEquivalentsAndRestrictedCash
-3995899
neot Net Increase Decrease In Cash Cash Equivalents And Restricted Cash
NetIncreaseDecreaseInCashCashEquivalentsAndRestrictedCash
-16276800
CY2016Q4 neot Cash Cash Equivalents And Restricted Cash At Carrying Value
CashCashEquivalentsAndRestrictedCashAtCarryingValue
11677852
CY2015Q4 neot Cash Cash Equivalents And Restricted Cash At Carrying Value
CashCashEquivalentsAndRestrictedCashAtCarryingValue
37948603
CY2017Q2 neot Cash Cash Equivalents And Restricted Cash At Carrying Value
CashCashEquivalentsAndRestrictedCashAtCarryingValue
7681953
CY2016Q2 neot Cash Cash Equivalents And Restricted Cash At Carrying Value
CashCashEquivalentsAndRestrictedCashAtCarryingValue
21671803
us-gaap Interest Paid
InterestPaid
366567
us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period.&nbsp;&nbsp;Actual results could differ from those estimates.</p></div>
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
875300
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
3251
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
88904
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Concentrations of Credit Risk</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents. The Company maintains deposits in federally insured financial institutions in excess of federally insured limits. The Company has not experienced any losses in such accounts and believes it is not exposed to significant risk on its cash due to the financial position of the depository institution in which those deposits are held.</p></div>
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1654348
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.95
neot Number Of Full Time Employees Before Restructuring
NumberOfFullTimeEmployeesBeforeRestructuring
6
neot Number Of Full Time Employees After Restructuring
NumberOfFullTimeEmployeesAfterRestructuring
2
CY2016Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
21471803
CY2016Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
200000
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1725605
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1444118
CY2017Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
100577
CY2016Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
254049
CY2017Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
71120
CY2016Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
144729
CY2017Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
71257
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
871203
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.88
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.06
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
1.35
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.47
CY2017Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
290973
CY2016Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
172676
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
422069
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
887363
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
2042823
CY2017Q2 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
4342888
neot Non Cancelable Operating Lease Agreement Date
NonCancelableOperatingLeaseAgreementDate
2015-01-20
neot Lease Expiration Period
LeaseExpirationPeriod
2020-03
CY2017Q2 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
261144
CY2017Q2 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
410848
CY2017Q2 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
431507
CY2017Q2 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
109293
CY2017Q2 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
1212792
CY2017Q2 us-gaap Operating Leases Future Minimum Payments Receivable Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsReceivableRemainderOfFiscalYear
111072
CY2017Q2 us-gaap Operating Leases Future Minimum Payments Receivable In Two Years
OperatingLeasesFutureMinimumPaymentsReceivableInTwoYears
342374
CY2017Q2 us-gaap Operating Leases Future Minimum Payments Receivable In Three Years
OperatingLeasesFutureMinimumPaymentsReceivableInThreeYears
352645
CY2017Q2 us-gaap Operating Leases Future Minimum Payments Receivable In Four Years
OperatingLeasesFutureMinimumPaymentsReceivableInFourYears
90143
CY2017Q2 us-gaap Operating Leases Future Minimum Payments Receivable
OperatingLeasesFutureMinimumPaymentsReceivable
896234

Files In Submission

Name View Source Status
0001564590-17-017119-index-headers.html Edgar Link pending
0001564590-17-017119-index.html Edgar Link pending
0001564590-17-017119.txt Edgar Link pending
0001564590-17-017119-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
neot-10q_20170630.htm Edgar Link pending
neot-20170630.xml Edgar Link completed
neot-20170630.xsd Edgar Link pending
neot-20170630_cal.xml Edgar Link unprocessable
neot-20170630_def.xml Edgar Link unprocessable
neot-20170630_lab.xml Edgar Link unprocessable
neot-20170630_pre.xml Edgar Link unprocessable
neot-ex311_7.htm Edgar Link pending
neot-ex321_6.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending